AdvisorShares Psychedelics ETF (PSIL) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores PSIL 1.4 out of 10 — highest on Return (2.1), lowest on Risk (0.1). Its ten largest holdings are 70% of the fund.
What stands out in PSIL's data
A focused strategy tied to the psychedelics industry, within health and biotech.
Profitability sits in line with the typical health and biotech fund — but the ride has been brutal, and the fee is steep.
EBITDA margin of 20.5% matches the peer median. The fund has lost 92.6% from its peak over five years, and its 1.84% expense ratio is high.
A niche sleeve for a portfolio willing to bet on an early-stage medical sector.
How is PSIL rated? ETF Copilot scores AdvisorShares Psychedelics ETF (PSIL) 1.4 out of 10
As of October 9, 2026, ETF Copilot scores AdvisorShares Psychedelics ETF (PSIL) 1.4 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 1.4 / 10
- Risk: 0.1 / 10
- Quality: 2.0 / 10
- Return: 2.1 / 10
What's inside PSIL?
What's inside PSIL: Size (Large 16%, Mid 9%, Small 75%); Geography (International 35%, US 65%).
What are PSIL's top holdings? The ten largest are 70% of the fund
Compass Pathways, Definium Therapeutics, Helus Pharma, Abbvie, Eli Lilly, Neurocrine Biosciences, NRX Pharmaceuticals, Johnson & Johnson, Relmada Therapeutics and Bright Minds Biosciences are PSIL's largest holdings, in that order.
More concentrated than 83% of Health & Biotech ETFs.
Half of PSIL's weight sits in its 6 largest positions, and once those weights are taken into account it behaves like 15 equally weighted holdings.
What is PSIL's expense ratio? 1.84% a year
As of October 9, 2026, PSIL charges 1.84% a year, yields 7.72% and holds $48M in assets across 23 positions.
| Measure | PSIL |
|---|---|
| Expense ratio | 1.84% |
| Dividend yield | 7.72% |
| Assets under management | $48M |
| Holdings | 23 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “AdvisorShares Psychedelics ETF (PSIL) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/psil
ETF Copilot Pro unlocks PSIL's price and what each holding weighs.
Try Pro free →